Cellectar Biosciences ROA 2010-2025 | CLRB
Cellectar Biosciences ROA - Return on Assets Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Total Assets | Return on Assets |
2025-03-31 | $-0.03B | $0.02B | -93.46% |
2024-12-31 | $-0.05B | $0.03B | -134.33% |
2024-09-30 | $-0.05B | $0.04B | -168.60% |
2024-06-30 | $-0.05B | $0.03B | -203.77% |
2024-03-31 | $-0.06B | $0.04B | -300.00% |
2023-12-31 | $-0.04B | $0.01B | -307.14% |
2023-09-30 | $-0.05B | $0.02B | -272.73% |
2023-06-30 | $-0.04B | $0.01B | -222.22% |
2023-03-31 | $-0.03B | $0.02B | -156.10% |
2022-12-31 | $-0.03B | $0.02B | -125.25% |
2022-09-30 | $-0.03B | $0.02B | -94.74% |
2022-06-30 | $-0.03B | $0.03B | -72.99% |
2022-03-31 | $-0.02B | $0.03B | -60.38% |
2021-12-31 | $-0.02B | $0.04B | -52.75% |
2021-09-30 | $-0.02B | $0.04B | -43.14% |
2021-06-30 | $-0.02B | $0.05B | -43.72% |
2021-03-31 | $-0.02B | $0.06B | -45.28% |
2020-12-31 | $-0.02B | $0.06B | -56.64% |
2020-09-30 | $-0.02B | $0.02B | -90.91% |
2020-06-30 | $-0.02B | $0.02B | -98.36% |
2020-03-31 | $-0.01B | $0.01B | -100.00% |
2019-12-31 | $-0.01B | $0.01B | -93.33% |
2019-09-30 | $-0.02B | $0.02B | -95.24% |
2019-06-30 | $-0.02B | $0.02B | -95.52% |
2019-03-31 | $-0.02B | $0.01B | -116.36% |
2018-12-31 | $-0.02B | $0.02B | -115.38% |
2018-09-30 | $-0.02B | $0.02B | -136.00% |
2018-06-30 | $-0.02B | $0.01B | -150.00% |
2018-03-31 | $-0.02B | $0.01B | -130.43% |
2017-12-31 | $-0.02B | $0.01B | -117.65% |
2017-09-30 | $-0.02B | $0.01B | -113.21% |
2017-06-30 | $-0.01B | $0.01B | -107.69% |
2017-03-31 | $-0.01B | $0.02B | -104.00% |
2016-12-31 | $-0.01B | $0.02B | -87.80% |
2016-09-30 | $0.00B | $0.01B | -23.53% |
2016-06-30 | $0.00B | $0.01B | -25.81% |
2016-03-31 | $0.00B | $0.01B | -27.59% |
2015-12-31 | $-0.01B | $0.01B | -58.82% |
2015-09-30 | $-0.01B | $0.01B | -92.31% |
2015-06-30 | $-0.01B | $0.01B | -57.14% |
2015-03-31 | $-0.01B | $0.01B | -60.87% |
2014-12-31 | $-0.01B | $0.01B | -74.42% |
2014-09-30 | $-0.01B | $0.02B | -97.30% |
2014-06-30 | $-0.01B | $0.01B | -129.03% |
2014-03-31 | $-0.01B | $0.01B | -108.11% |
2013-12-31 | $-0.01B | $0.01B | -93.02% |
2013-09-30 | $-0.01B | $0.01B | -68.09% |
2013-06-30 | $-0.01B | $0.01B | -85.11% |
2013-03-31 | $-0.01B | $0.01B | -85.11% |
2012-12-31 | $-0.01B | $0.01B | -85.71% |
2012-09-30 | $-0.01B | $0.01B | -85.71% |
2012-06-30 | $-0.01B | $0.01B | -82.05% |
2012-03-31 | $-0.01B | $0.01B | -102.86% |
2011-12-31 | $-0.01B | $0.01B | -118.52% |
2011-09-30 | $-0.01B | $0.01B | -114.29% |
2011-06-30 | $-0.01B | $0.01B | -117.65% |
2011-03-31 | $0.00B | $0.00B | -123.08% |
2010-12-31 | $0.00B | $0.01B | 44.44% |
2010-09-30 | $-0.01B | $0.00B | -200.00% |
2010-06-30 | $-0.01B | $0.00B | -208.00% |
2010-03-31 | $-0.02B | $0.01B | -246.15% |
2009-12-31 | $-0.02B | $0.01B | -340.74% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.018B | $0.000B |
Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $240.237B | 28.89 |
Boston Scientific (BSX) | United States | $154.040B | 38.56 |
Stryker (SYK) | United States | $147.507B | 30.84 |
EssilorLuxottica (ESLOY) | France | $130.320B | 0.00 |
Medtronic (MDT) | Ireland | $110.401B | 15.65 |
Lonza Group Ag (LZAGY) | Switzerland | $51.194B | 0.00 |
Haleon (HLN) | United Kingdom | $47.171B | 26.90 |
ResMed (RMD) | United States | $37.523B | 28.18 |
Agilent Technologies (A) | United States | $33.417B | 21.78 |
GE HealthCare Technologies (GEHC) | United States | $32.959B | 15.65 |
Terumo (TRUMY) | Japan | $27.294B | 35.45 |
Koninklijke Philips (PHG) | Netherlands | $23.014B | 16.15 |
Insulet (PODD) | United States | $21.880B | 85.88 |
Zimmer Biomet Holdings (ZBH) | United States | $18.269B | 11.73 |
Baxter (BAX) | United States | $15.698B | 11.72 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.073B | 0.00 |
Demant (WILYY) | Denmark | $9.110B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.474B | 22.53 |
Lantheus Holdings (LNTH) | United States | $5.601B | 14.13 |
Prestige Consumer Healthcare (PBH) | United States | $4.184B | 18.69 |
Perrigo (PRGO) | Ireland | $3.678B | 9.32 |
Haemonetics (HAE) | United States | $3.510B | 15.99 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
ICU Medical (ICUI) | United States | $3.221B | 23.75 |
Envista Holdings (NVST) | United States | $3.210B | 26.68 |
GN Store Nord (GNNDY) | Denmark | $2.346B | 19.43 |
QuidelOrtho (QDEL) | United States | $1.939B | 13.34 |
LeMaitre Vascular (LMAT) | United States | $1.916B | 42.83 |
AtriCure (ATRC) | United States | $1.621B | 0.00 |
Acuren (TIC) | United States | $1.311B | 0.00 |
AdaptHealth (AHCO) | United States | $1.182B | 12.00 |
Neogen (NEOG) | United States | $1.070B | 13.69 |
Green Thumb Industries (GTBIF) | United States | $1.063B | 23.91 |
BioLife Solutions (BLFS) | United States | $1.036B | 0.00 |
Phibro Animal Health (PAHC) | United States | $1.004B | 12.83 |
Kestra Medical Technologies (KMTS) | United States | $0.906B | 0.00 |
InMode (INMD) | Israel | $0.870B | 8.76 |
CeriBell (CBLL) | United States | $0.710B | 0.00 |
Evolus (EOLS) | United States | $0.620B | 0.00 |
Owens & Minor (OMI) | United States | $0.578B | 4.79 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.568B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.519B | 0.00 |
Valneva SE (VALN) | France | $0.477B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.423B | 0.00 |
Surmodics (SRDX) | United States | $0.415B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.384B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.328B | 12.05 |
SNDL (SNDL) | Canada | $0.326B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.300B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.279B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.274B | 23.10 |
Cerus (CERS) | United States | $0.262B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.253B | 0.00 |
ZimVie (ZIMV) | United States | $0.247B | 11.22 |
Brainsway (BWAY) | Israel | $0.232B | 61.30 |
Canopy Growth (CGC) | Canada | $0.230B | 0.00 |
Quanterix (QTRX) | United States | $0.229B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.228B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.224B | 66.33 |
Biote (BTMD) | United States | $0.218B | 6.14 |
Omeros (OMER) | United States | $0.198B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.198B | 0.00 |
Organigram Global (OGI) | Canada | $0.182B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.181B | 14.74 |
High Tide (HITI) | Canada | $0.177B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.175B | 0.00 |
Exagen (XGN) | United States | $0.150B | 0.00 |
Vireo Growth (VREOF) | United States | $0.131B | 0.00 |
FitLife Brands (FTLF) | United States | $0.121B | 14.84 |
Jin Medical (ZJYL) | China | $0.103B | 0.00 |
Veru (VERU) | United States | $0.098B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
Fonar (FONR) | United States | $0.088B | 11.32 |
Apyx Medical (APYX) | United States | $0.086B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
MacroGenics (MGNX) | United States | $0.085B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.078B | 0.00 |
Zynex (ZYXI) | United States | $0.076B | 0.00 |
Cytosorbents (CTSO) | United States | $0.075B | 0.00 |
InterCure (INCR) | Israel | $0.069B | 0.00 |
Agape ATP (ATPC) | $0.065B | 0.00 | |
ImmuCell (ICCC) | United States | $0.062B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
Nephros (NEPH) | United States | $0.044B | 59.43 |
Modular Medical (MODD) | United States | $0.043B | 0.00 |
United-Guardian (UG) | United States | $0.037B | 12.89 |
Rockwell Medical (RMTI) | United States | $0.030B | 0.00 |
Safety Shot (SHOT) | United States | $0.023B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
Flora Growth (FLGC) | United States | $0.015B | 0.00 |
INLIF (INLF) | $0.014B | 0.00 | |
Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
Senestech (SNES) | United States | $0.007B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |